Gaeta ex rel. A.G. v. Perrigo Pharmaceuticals Co.

469 F. App'x 556
CourtCourt of Appeals for the Ninth Circuit
DecidedFebruary 27, 2012
DocketNo. 09-15001
StatusPublished
Cited by10 cases

This text of 469 F. App'x 556 (Gaeta ex rel. A.G. v. Perrigo Pharmaceuticals Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gaeta ex rel. A.G. v. Perrigo Pharmaceuticals Co., 469 F. App'x 556 (9th Cir. 2012).

Opinion

ORDER

The Supreme Court having vacated our prior opinion for farther consideration in light of PLIVA, Inc. v. Mensing, — U.S. -, 131 S.Ct. 2567, 180 L.Ed.2d 580 (2011), see L. Perrigo Co. v. Gaeta, — U.S.-, 132 S.Ct. 497, 181 L.Ed.2d 343 (2011), we now AFFIRM the district court’s grant of summary judgment in favor of Perrigo Pharmaceuticals Company.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Greager v. McNeil PPC, Inc.
N.D. Illinois, 2019
Moore v. Zydus Pharmaceuticals (USA), Inc.
277 F. Supp. 3d 873 (E.D. Kentucky, 2017)
Stephens v. Teva Pharmaceuticals, U.S.A., Inc.
70 F. Supp. 3d 1246 (N.D. Alabama, 2014)
Schrock v. Wyeth Inc.
Tenth Circuit, 2013
Teva Pharmaceuticals USA, Inc. v. Superior Court
217 Cal. App. 4th 96 (California Court of Appeal, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
469 F. App'x 556, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gaeta-ex-rel-ag-v-perrigo-pharmaceuticals-co-ca9-2012.